Proactive Infliximab Is Superior to Either Conventional Infliximab and Vedolizumab in Inflammatory Bowel Disease

AuthID
P-00W-HHY
10
Author(s)
Rodrigues, I
·
Botto, I
·
Fernandes, S
·
Bernardo, S
·
Gonçalves, AR
·
Santos, PM
·
Valente, A
·
Marinho, RT
Tipo de Documento
Abstract
Year published
2022
Publicado
in JOURNAL OF CROHNS & COLITIS, ISSN: 1873-9946
Volume: 16, Páginas: I543-I543 (1)
Indexing
Publication Identifiers
Wos: WOS:000778573400740
Source Identifiers
ISSN: 1873-9946
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.